Lung Cancer Clinical Trials

A look at the following clinical trial: Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection

A look at the following clinical trial: Biomarker Discovery and Validation in Lung Cancer

A look at the following clinical trial: DNA Analysis in Predicting Lung Cancer Risk

A look at the following clinical trial: Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

A look at the following clinical trial: Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

A look at the following clinical trial: Surgical Versus Non-surgical Staging of Lung Cancer

A look at the following clinical trial: Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

A look at the following clinical trial: Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Provides information to potential participants on the following clinical trial: Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer

Provides information to potential participants on the following clinical trial: A Phase II Study of TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)